We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

190 hedge funds and large institutions have $1.51B invested in Spectrum Pharmaceuticals Inc in 2018 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 76 increasing their positions, 49 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

55% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 49

55% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 22

18% more call options, than puts

Call options by funds: $21.9M | Put options by funds: $18.5M

6% more funds holding

Funds holding: 180190 (+10)

20% less capital invested

Capital invested by funds: $1.87B → $1.51B (-$365M)

Holders
190
Holders Change
+10
Holders Change %
+5.56%
% of All Funds
4.34%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
34
Increased
76
Reduced
49
Closed
22
Calls
$21.9M
Puts
$18.5M
Net Calls
+$3.38M
Net Calls Change
-$6.31M
Name Holding Trade Value Shares
Change
Change in
Stake
Manulife (Manufacturers Life Insurance)
76
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.11M -$165K -7,646 -10%
Thrivent Financial for Lutherans
77
Thrivent Financial for Lutherans
Minnesota
$1.1M +$24.3K +1,123 +2%
State Board of Administration of Florida Retirement System
78
State Board of Administration of Florida Retirement System
Florida
$1.07M
PI
79
PineBridge Investments
New York
$1.05M -$51.2K -2,368 -4%
TPSF
80
Texas Permanent School Fund
Texas
$1.04M +$38K +1,755 +3%
State of Tennessee, Department of Treasury
81
State of Tennessee, Department of Treasury
Tennessee
$1.04M -$14K -645 -1%
UBS AM
82
UBS AM
Illinois
$997K
ProShare Advisors
83
ProShare Advisors
Maryland
$975K -$38K -1,757 -3%
ERSOT
84
Employees Retirement System of Texas
Texas
$974K +$433K +20,000 +53%
PVAM
85
Pacific View Asset Management
California
$972K +$1.25M +57,885 New
Millennium Management
86
Millennium Management
New York
$899K +$1.16M +53,517 New
Connor, Clark & Lunn Investment Management (CC&L)
87
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$853K +$1.1M +50,790 New
PVI
88
Pura Vida Investments
New York
$840K +$1.08M +50,000 New
GTC
89
Ghost Tree Capital
New York
$793K +$394K +18,200 +63%
Citigroup
90
Citigroup
New York
$771K -$3.54M -163,390 -78%
MIM
91
MetLife Investment Management
New Jersey
$770K
LSERS
92
Louisiana State Employees Retirement System
Louisiana
$732K +$36.8K +1,700 +4%
D.E. Shaw & Co
93
D.E. Shaw & Co
New York
$679K -$8.38M -387,421 -91%
KAM
94
Kazazian Asset Management
Florida
$632K
Royal Bank of Canada
95
Royal Bank of Canada
Ontario, Canada
$621K +$63.5K +2,934 +9%
MSL
96
Mackay Shields LLC
New York
$613K +$51.9K +2,400 +7%
PA
97
Profund Advisors
Maryland
$611K +$362K +16,721 +85%
RE
98
RBC Europe
United Kingdom
$588K +$216K +10,000 +40%
MLICM
99
Metropolitan Life Insurance Company (MetLife)
New York
$544K
SOADOR
100
State of Alaska Department of Revenue
Alaska
$543K +$38K +1,755 +6%

SPPI Hedge Fund Activity: Q3 2018 in Review

190 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q3 2018, worth a combined $1.51B — down 20% from $1.87B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new SPPI positions and 22 closed out — a net gain of 12 holders — while 76 added to existing stakes and 49 trimmed.

The largest buyer was ArrowMark Colorado Holdings, adding an estimated $50.5M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $71.7M sold.

  • 190 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q3 2018, up from 180 in Q2 2018.
  • Funds reported $1.51B of Spectrum Pharmaceuticals Inc stock for Q3 2018, down 20% quarter-over-quarter.
  • 34 funds opened new Spectrum Pharmaceuticals Inc positions in Q3 2018 and 22 closed out, a net change of +12 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q3 2018 was ArrowMark Colorado Holdings, an estimated $50.5M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q3 2018 was Avoro Capital Advisors, an estimated $71.7M sold.

Based on aggregated 13F filings for Q3 2018.